| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GRI Bio, Inc. | Director | Stock Option (Right to Buy) | 23,605 | $20,775 | $0.6857 | 18 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GRI | GRI Bio, Inc. | 18 Sep 2025 | 1 | $0 | 4 | Director | 22 Sep 2025, 16:05 |
| GRI | GRI Bio, Inc. | 26 Aug 2025 | 1 | $0 | 4 | Director | 27 Aug 2025, 08:25 |
| GRI | GRI Bio, Inc. | 13 Aug 2025 | 1 | $0 | 4 | Director | 14 Aug 2025, 16:58 |
| GRI | GRI Bio, Inc. | 23 Jan 2025 | 1 | +$20,775 | 4 | Director | 24 Jan 2025, 17:57 |
| GRI | GRI BIO, Inc. | 10 Aug 2023 | 1 | +$100,001 | 4 | Director | 14 Aug 2023, 17:06 |
| GRI | Vallon Pharmaceuticals, Inc. | 15 Feb 2022 | 1 | +$343,430 | 4 | Chief Executive Officer, Director | 01 Mar 2022, 16:04 |
| GRI | Vallon Pharmaceuticals, Inc. | 14 May 2021 | 1 | $0 | 4 | Chief Executive Officer, Director | 18 May 2021, 16:06 |